Developing Viability Index for Machine Perfused Livers

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 1, 2024

Study Completion Date

June 1, 2025

Conditions
Liver Cirrhoses
Interventions
DIAGNOSTIC_TEST

Liver Biopsy

For measurement of tissue co-factor levels, we will take needle biopsies of transplanted livers immediately after procurement, immediately prior to implantation (at the end of preservation), 30 minutes after portal vein reperfusion, and 30 minutes after hepatic artery reperfusion. For those livers that have more than 60 minutes between portal vein and hepatic artery reperfusion, an additional biopsy will be performed at 60 minutes after portal vein reperfusion. Post-procurement biopsies will be collected regardless of where the liver was obtained.

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Shriners

UNKNOWN

lead

Massachusetts General Hospital

OTHER